Clinical trials
Observational Hepatitis B trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
43 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2005 | 2 |
| 2008 | 3 |
| 2009 | 1 |
| 2010 | 5 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 5 |
| 2014 | 2 |
| 2015 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 2 |
| 2021 | 3 |
| 2023 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 26 |
| Recruiting | 5 |
| Terminated | 5 |
| Active, not recruiting | 3 |
| Unknown status | 2 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 6 |
| National Institutes of Health Clinical Center (CC) | 3 |
| Dynavax Technologies Corporation | 2 |
| University of Pennsylvania | 2 |
| University of Pittsburgh | 2 |
| Baylor College of Medicine | 1 |
| Beckman Coulter, Inc. | 1 |
| Exact Sciences Corporation | 1 |
| Genlantis Diagnostics | 1 |
| Gilead Sciences | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatitis B | 43 |
| Hepatitis C | 14 |
| HIV Infections | 6 |
| Hepatitis | 6 |
| Acquired Immunodeficiency Syndrome | 5 |
| Carcinoma, Hepatocellular | 5 |
| Liver Diseases | 5 |
| Liver Neoplasms | 4 |
| Diabetes Mellitus | 3 |
| Fibrosis | 3 |
Trials
Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.